Form 4: Catalent Director Discloses Share Disposition Following Merger

A Form 4 filing reveals a Catalent director's disposition of shares and restricted stock units following the company's merger with Creek Parent, Inc.

Summary

• This document is a Form 4 filing, indicating changes in beneficial ownership for Michael J. Barber, a director at Catalent, Inc.
• The filing is triggered by the merger of Catalent with Creek Parent, Inc. on December 18, 2024.
• As a result of the merger, Mr. Barber's holdings of 18,052 common stock shares were disposed of.
• Additionally, his restricted stock units (RSUs) were also cancelled and converted into cash.
• Each share of Catalent common stock was converted into the right to receive $63.50 in cash.
• RSUs were converted into cash based on the number of shares they represented, multiplied by the merger consideration of $63.50 per share.

Sentiment

Score: 7

Explanation: The document is a routine filing related to a completed merger, which is a neutral event. The sentiment is slightly positive as the merger has been completed as expected.

Industry Context

This filing reflects the completion of a merger, a common event in the pharmaceutical and healthcare industry, where companies often consolidate to achieve synergies or expand market reach.

Comparison to Industry Standards

• Mergers and acquisitions are a common strategy in the pharmaceutical and healthcare industry, with companies like Thermo Fisher Scientific and Danaher also engaging in similar transactions.
• The valuation of $63.50 per share would be compared to other recent acquisitions in the sector to assess its fairness and market value.

Stakeholder Impact

• Shareholders received $63.50 per share in cash as a result of the merger.
• Employees with RSUs received cash payments based on the value of their units.

Key Dates

Keywords

Merger, Form 4, Catalent, Director, Share Disposition, Restricted Stock Units, Creek Parent, Beneficial Ownership